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Summary 
The HIV-1 Rev protein increases the cytoplasmic levels 
of unspliced and singly spliced target transcripts in 
metazoan systems. Based on experiments that indi- 
cate a similar function of Rev in the yeast S. cerevisiae, 
we have identified a yeast protein that interacts with 
the effector domain of Rev. The protein, Riplp, is a 
novel small nucleoporin-like protein, some of which 
is associated with nuclear pores. Its closest known 
yeast relative is a nuclear pore component also impli- 
cated in mRNA transport from nucleus to cytoplasm. 
Analysis of strains that overexpress Riplp or that are 
deleted for the RIP1 gene show that Rip1 p is important 
for the effect of Rev on gene expression, indicating 
that the physical interaction is of functional signifi- 
cance in vivo. The results suggest that Rev directly 
promotes the cytoplasmic transport of suitable tran- 
scripts by targeting them to the nuclear pore. 
Introduction 
The human immunodeficiency virus type 1 (HIV-1) Rev 
protein is a critical regulator of the viral life cycle and 
causes a switch from the early phase to the late phase of 
gene expression. In the early phase, products from fully 
spliced RNAs, including Rev, are synthesized. In the late 
phase, Rev function results in the appearance of unspliced 
or partially spliced viral transcripts in the cytoplasm, where 
they encode the viral structural proteins Gag, Pol, and Env 
(Feinberg et al., 1986; Sodroski et al., 1986). The hallmark 
of Rev activity and that of similar proteins from related 
retroviruses (such as Rex from human T cell leukemia 
virus type I [HTLV-I]) is therefore the export of suitable 
target transcripts from the nucleus to the cytoplasm. In 
many experimental systems, this relocalization is also ac- 
companied by a reduction in the cytoplasmic levels of fully 
spliced viral RNAs (Emerman et al., 1989; Felber et al., 
1989; Malim et al., 1989b; Malim and Cullen, 1993). 
These observations have generated two hypotheses to 
explain Rev activity: either Rev inhibits some aspect of 
pre-mRNA splicing, which leads indirectly to enhanced 
pre-mRNA export, or Rev directly promotes pre-mRNA 
export, which has an indirect negative effect on pre-mRNA 
splicing (Cullen and Malim, 1991). Although both explana- 
tions are still possible (and are not necessarily mutually 
exclusive), recent experiments suggest that the direct 
mode of action of Rev is more likely to involve RNA export 
than pre-mRNA splicing for the following reasons. First, 
in certain experimental systems such as T lymphocytes, 
Rev-dependent relocalization of RNA is not accompanied 
by a reduction in the cytoplasmic levels of fully spliced 
mRNAs (Malim and Cullen, 1993). Second, although 
largely nuclear in mammalian cells, Rev is a shuttling pro- 
tein and accompanies Rev response element (RRE)- 
containing RNAs to the cytoplasm (Kalland et al., 1994; 
Meyer and Malim, 1994). Third, recent experiments in the 
oocyte system indicate that Rev can promote export of 
target ranscripts that are not recognized by the pre-mRNA 
splicing machinery (Fischer et al., 1994). Although these 
conclusions favor RNA transport as the cellular process 
targeted by Rev, more definitive conclusions require struc- 
ture-function studies on the direct biochemical activities 
of Rev. 
Mutagenesis and domain swap experiments have 
shown that the 116 amino acids of Rev contain at least 
two domains necessary for RNA export activity. The basic 
arginine-rich domain near the amino terminus determines 
RNA target selectivity by binding to the RRE, a highly 
structured 240 base RNA sequence located within the viral 
env intron (Hadzopoulou-Cladaras et al., 1989; Daly et al., 
1989; Zapp and Green, 1989; Kjems et al., 1991a). This 
domain also contributes to Rev oligomerization as well as 
to Rev nuclear localization (Malim et al., 1989a; Hope et 
al., 1990; Zapp et al., 1991). The small ( -  10 amino acid) 
leucine-rich effector domain is also necessary for pre- 
mRNA export (Malim et al., 1991). Unlike mutations in the 
arginine-rich domain, however, mutations in the effector 
domain do not interfere with RNA binding, Rev oligomer- 
ization, or Rev subcellular localization (Malim et al., 1989a, 
1991; Mermer et al., 1990; Zapp et al., 1991; Hope et 
al., 1992). Therefore, the effector domain has no direct 
connection to known biochemical processes. If we assume 
that Rev functions directly to promote RNA export, the 
identification of factors contacted by the effector domain 
might illuminate cellular strategies used to export RNA 
from the nucleus to the cytoplasm. 
To identify such factors and to study Rev function, we 
recently established a Rev-dependent system in the yeast 
Saccharomyces cerevisiae (Stutz and Rosbash, 1994). 
Because reliable nuclear-cytoplasmic fractionation is diffi- 
cult in yeast, the effect of Rev on pre-mRNA localization 
was indirectly monitored by examining the expression of 
RRE-containing transcripts encoding a functional CUP1 
gene product. Cuplp is a copper chelator and allows cells 
expressing CUP1 to grow on copper-containing media in 
a dose-dependent manner (Hamer et al., 1985; Lesser 
and Guthrie, 1993). Two key reporter gene constructs, 
pre-mRNA coding sequence-CUP1-RRE (PC-CUP- 
RRE) and mRNA coding sequence-CUP1-RRE (MC- 
CUP-RRE), contain an inefficiently spliced 65 bp synthetic 
intron at the 5' end of the CUP1 coding sequence (Legrain 
and Rosbash, 1989; Stutz and Rosbash, 1994; Figure 1). 
In the PC-CUP-RRE construct, the intron sequence is 
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Figure 1. Schematic Drawing of the CUP1 Reporter Constructs 
Each CUPI transcription unit is driven by the strong GPD constitutive 
promoter (open box) (Guthrie and Fink, 1991). The transcription initia- 
tion site corresponds to the start of the arrow. The CUP1 coding region 
is shown as a stippled box. In both constructs, a 65 bp inefficiently 
spliced intron interrupts the CUP1 coding region after the third codon; 
the intron contains consensus 5' splice site, branchpoint, and 3' splice 
site sequences (Legrain and Rosbash, 1989). Both constructs encode 
at their 3' end, after the CUP1 stop codon, a 450 base sequence con- 
taining the complete RRE. The transcripts terminate beyond the RRE 
within the phosphoglycerate kinase (PGK) terminator (not shown; 
Guthrie and Fink, 1991). In the PC-CUP-RRE construct, Cuplp is 
encoded only from the pre-mRNA; in the MC-CUP=RRE constr~ct, 
Cuplp is encoded from the spliced RNA only. The copper resistance 
conferred by these constructs to the yeast host strain in the presence 
of wild-type or mutant Rev.expressing plasmids is indicated on the 
right and summarized from Stutz andRosbash (1994). The PC-CUP- 
RRE control strain (vector) grows up to 0.8 mM copper owing to some 
escape of the inefficiently spliced PC-CUP-RRE pre-mRNA into the 
cytoplasm. 
in-frame with the CUP1 coding sequence whereas the 
spliced mRNA contains early stop codons, preventing 
CUP1 expression from mRNA. For this construct, the abil- 
ity to grow in the presence of copper is the result of pre- 
mRNA translation and is taken as a measure of pre-mRNA 
export. In the MC-CUP-RRE construct, Cup lp  is encoded 
only by the spliced mRNA as the CUP1 coding sequence 
in the intron-containing transcript is out-of-frame. In this 
case, copper resistance reflects mRNA levels and is a 
function of splicing efficiency, Rev had a positive effect 
on pre-mRNA-derived gene expression, as evidenced by 
the enhanced copper resistance of the PC-CUP-RRE 
strain. MC-CUP-RRE expression, in contrast, was de- 
creased by Rev, In both cases, the Rev effects were RRE 
dependent. Moreover, a mutant in the RNA-binding do- 
main (RBD)/oligomerization domain (M4) of Rev and a mu- 
tant in the effector domain (M10) of Rev had no detectable 
activity (Figure 1; Stutz and Rosbash, 1994), suggesting 
that the mode of action of Rev in yeast might be similar 
to that in mammal ian systems (Malim et al., 1989a). 
To confirm and extend this connection, we report here 
additional experiments indicating that the function of Rev 
in yeast is indeed closely related to its activity in mamma- 
lian cells. Based on this conclusion, we identified in a two- 
hybrid screen (Fields and Song, 1989) a yeast gene whose 
product interacts with Rev, Rex, and the effector domain 
of Rev alone. This gene, RIP1, is inessential and encodes 
a novel small FG repeat-containing protein. Its closest 
known yeast relative is nucleoporin Rat~p/Nup159p, impli- 
cated in the export of polymerase II transcripts. Analysis 
of strains that overexpress R ip lp  or that are deleted for 
the RIP1 gene indicates that the physical interaction is of 
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Figure 2. Rex Is Functional in Yeast and Rev M10 Has a Dominant 
Negative Phenotype 
(A) The Rex effector domain can replace a nonfunctional Rev effector 
domain. Four different Rev or Rev-Rex fusion constructs (TRP1/ 
ARS1-CEN4) were introduced into a yeast strain containing either the 
PC-CUP-RRE or the MC-CUP-RRE reporter plasmid (LEU212p.m) to 
examine the effects of Rev or Rev-Rex fusions on pre-mRNA export or 
mRNA expression, respectively. The copper resistance of the double 
transformants was examined on Leu- Trp plates containing increasing 
concentrations of copper. The mutant Rev construct contains three 
amino acid changes in the effector domain (LCC81,85,89FKW); in 
the mutant Rev (Revm) plus Rex construct, a Rex sequence encoding 
amino acids 75-96 (Rex effector domain) was fused to mutant Rev; 
in mutant Rev plus mutant Rex (Rexm), an additional mutation (L90K) 
was introduced into the Rex effector domain. These three Rev and 
Rev-Rex constructs were a gift of T. Hope (A. A. Beeche et al., personal 
communication). 
(B) The M 10 effector domain mutation has a dominant negative pheno- 
type. Wild-type, M 10, and M4 mutant Rev constructs were expressed 
from a high copy number plasmid (TRPll2pm) in a yeast strain trans- 
formed with the PC-CUP-RRE reporter construct (LEU2121~m) and a 
low copy number wild-type Rev plasmid (URA3/ARS1-CEN4). M10 
contains the effector domain mutation LE78,79DL and M4 contains 
the RBD/oligomerization domain mutation YSN23,25,26DDL. The 
growth of the triple transformants was examined on Ur~ Leu- Trp 
plates in the presence of increasing copper concentrations. 
significance to Rev function in vivo. The experiments iden- 
tify a cellular protein that interacts with the Rev effector 
domain and suggest that this domain interacts directly with 
selected nucleoporins to promote RNA export. 
Results  
Rev Funct ions  in Yeast  as in Mammal ian  Systems 
To confirm and extend the similarity between Rev function 
in yeast and mammal ian cells, we carried out a number 
of additional experiments in yeast. First, we assayed the 
biological activity of the HTL.V-I Rex protein. Rex also con- 
tains an RBD/ol igomerization domain and a leucine-rich 
effector domain (Hanly et al., 1989). Moreover, these two 
functional domains are interchangeable with those from 
Rev (Rimsky et al., 1988, 1989; Hope et al., 1991; Weich- 
selbraun et al., 1992), indicating that these two viral pro- 
teins promote pre-mRNA export through similar mecha- 
nisms. Rev-Rex  chimeric constructs were used to test 
whether the effector domain of Rex is functional in yeast 
(Figure 2A). A sequence encoding the wild-type Rex ef- 
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fector domain (amino acids 75-96) or a mutant Rex (L90K) 
effector domain was fused to the 3' end of a mutant Rev 
sequence encoding a nonfunctional effector domain. The 
effect of these fusion constructs on pre-mRNA or mRNA 
expression was assayed in yeast strains containing the 
PC-CUP-RRE or the MC-CUP-RRE reporter construct, 
respectively (Figures 1 and 2A). Copper resistance of the 
PC-CUP-RRE strain was increased in the presence of 
wild-type Rev, but not mutant Rev. Addition of the wild-type 
Rex effector domain rescued the mutant Rev phenotype 
and allowed the yeast reporter strain to grow as in the 
presence of wild-type Rev. This positive effect on growth 
was eliminated by the Rex effector domain mutation L90K, 
which abolishes the activity of Rex in mammalian cells (T. 
Hope, personal communication). As predicted (Stutz and 
Rosbash, 1994), the opposite result was obtained in the 
MC-CUP-RRE reporter strain. Rev reduced the copper 
resistance of this strain, owing to the negative effect of 
Rev on mRNA expression; this effect was eliminated by 
mutant Rev and restored by fusion of the wild-type Rex 
effector domain, but it was not restored by fusion of the 
mutant Rex effector domain (Figure 2A). The results indi- 
cate that Rev and Rex have similar modes of action in 
yeast as in metazoan systems. 
We then verified that the classic M10 effector domain 
mutant, but not the M4 RBD/oligomerization domain mu- 
tant, has a dominant negative effect in yeast (Malim et al., 
1989a). In mammalian cells, M10 Rev inhibits wild-type 
Rev function by competing for RRE-containing target ran- 
scripts; M4 Rev is ineffective because it is an oligomeriza- 
tion mutant that competes poorly for stable RNA binding. 
Wild-type or mutant Rev proteins were expressed from a 
high copy number plasmid in a strain containing the PC- 
CUP-RRE reporter and wild-type Rev expressed from a 
low copy number plasmid. This strain grows up to 1.1-1.2 
mM copper, and the addition of a high copy number plas- 
mid expressing wild-type Rev had no further positive effect 
on PC-CUP-RRE expression. However, as in mammalian 
systems, addition of a high copy number plasmid express- 
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ing M 10 Rev had a dominant negative effect and interfered 
with the positive effect of wild-type Rev on pre-mRNA ex- 
port. This resulted in a decreased copper resistance of 
the reporter strain, which stopped growing at 1 mM copper; 
overexpression of M4 Rev was without effect, and the 
strain grew up to 1.1-1.2 mM copper, as in the presence 
of overexpressed wild-type Rev or vector (Figure 2B). The 
overexpressed proteins accumulated to similar levels as 
examined by Western blot analysis (data not shown). 
As a third indication that the mode of action of Rev in 
yeast is similar to that in mammalian systems, the effects 
of 14 mutants that span the entire effector domain were 
examined (Figure 3). The choice of these Rev mutants was 
dictated by the fact that they had already been examined in 
COS cells (Malim et al., 1991). The 14 yeast expression 
plasmids were introduced into the PC-CUP-RRE-con- 
taining reporter strain, and the results were compared with 
the previously described negative and positive controls. 
In the absence of Rev or in the presence of the M10 or 
M4 mutant Rev protein, copper resistance is at 0.8 mM; 
in the presence of wild-type Rev, copper resistance is in- 
creased to 1.1-1.2 mM (see Figure 1 ; Stutz and Rosbash, 
1994). 
Most of the mutants had the same effects in yeast as 
in COS cells (Figure 3). Mutants M16, M20, M23, and M24 
were indistinguishable from wild-type Rev. Mutants M10, 
M21, M22, and M27-M29 had strong negative effects on 
Rev function in yeast, as they lowered copper resistance 
to 0.8 mM, indistinguishable from the negative control. 
The M18 mutant, which has an intermediate phenotype 
in COS cells, also had an intermediate copper resistance 
(1 mM) in yeast. Only three mutants (M17, M19, and M25, 
indicated by an asterisk in Figu re 3) more severely affected 
the function of Rev in yeast than in mammalian cells, and 
no mutant had a stronger effect in COS cells than in yeast. 
The more severe effect in yeast of the three Rev mutations 
might be related to the relatively weak effect of wild-type 
Rev in this organism. In the main, the analysis of these 
14 Rev mutants suggests that the effector domain of Rev 
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Figure 3. Rev Effector Domain Mutations and 
Their Effects in COS Cells and Yeast 
The indicated Rev effector domain mutations 
and their effects on the activity of Rev in COS 
cells have been published previously (Malim et 
al., 1991). The three critical eucines are cir- 
cled. gTAT activity scores the ability of various 
Rev mutants to induce expression of the 72 
amino acid form of TAT. The effects of the same 
mutations on the Rev response in yeast were 
analyzed by transforming the various Rev + 
expressing plasmids (TRP1/ARS1-CEN4) into 
a yeast strain containing the PC-CUP-RRE re- 
porter construct (LEU2/2pm) (see Figure 1). 
The copper resistance of the double trans+ 
formants was determined by growth on selec.- 
tive plates containing increasing copper con- 
centrations. See text for an explanation of the 
asterisk. WT, wild type. 
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undergoes imilar interactions in yeast and in mammalian 
systems. 
Identification of a Yeast Protein That Interacts 
with Rev in the Two-Hybrid System 
To find the yeast targets of the effector domain of Rev, 
we screened for Rev-interacting proteins (RIPs) with the 
yeast two-hybrid system and a yeast genomic library. In 
an initial screen with wild-type Rev, we identified a large 
number of proteins that apparently interacted with the argi- 
nine-rich RBD of Rev. To eliminate this ource of back- 
ground, we used the Rev mutant MB3 as the bait in the 
two-hybrid screen. In the MB3 mutant, Arg-41 to Arg-43 
are replaced by three glycines; this mutation has no effect 
on the effecter domain activity of Rev (Hope et al., 1990; 
McDonald et al., 1992). 
A number of strong MB3 RIPs were identified and tested 
for an interaction with M10 Rev. Only one (Riplpl) failed 
to show a detectable interaction with M10 Rev. The inter- 
action of the Riplpl fusion (encoding amino acids 148- 
275 of Riplp; see below) with additional b~.it constructs 
was then tested (Figure 4). 
Interestingly, Riplpl also interacted well with a 30 
amino acid segment of Rev spanning just the effector do- 
main (Figure 4). This interaction was sensitive to mutations 
M21 and M22, which replace critical effector domain leu- 
cines with aspartic acids and which abolish Rev function 
in vivo (see Figure 3). Importantly, Riplpl also interacted 
with Rex (Figure 4). The Riplpl and Riplp fusions (encod- 
ing the complete Riplp, amino acids 1-430; see below) 
showed similar series of interactions with the panel of bait 
fusions. However, the interaction strengths appear lower 
with the total protein. This is likely due to a lower steady- 
state level of the complete Riplp fusion compared with 
Rip1 pl, as assayed by Western blotting (data not shown). 
The Rev wild-type "bait"/Rev wild-type "prey" combina- 
tion examines Rev dimerization (Figure 4). This homotypic 
interaction requires an intact RBD/oligomerization domain 
but is insensitive to the M10 effector domain mutation 
(Zapp et al., 1991). The strong interaction between Rev 
M10 and Rev wild type serves as a positive indicator of 
Rev M10 bait expression, consistent with Western blot 
data (not shown). The data indicate that Riplpl and Rip1 p 
interact with the effector domain of Rev. 
Sequence Analysis of the RIP1 Gene 
The Riplpl two-hybrid clone contained a 375 bp EcoRI 
insert, which was sequenced and also used as a probe 
to clone the complete RIP1 gene from a yeast genomic 
library. The open reading frame is uninterrupted and en- 
codes a 430 amino acid protein with three features charac- 
teristic of yeast nucleoporin proteins (Dingwall, 1993; Rout 
and Wente, 1994; Figure 5). First, there is a domain con- 
taining 27 striking XXFG tetrapeptide repeats. Second, 
there is a high frequency of serines, threonines, and aspar- 
agines in the small spacer regions between the repeats. 
Third, the repeat domain is lacking acidic residues. The 
Riplpl polypeptide contains eight XXFG repeats ex- 
pressed in-frame with the acidic domain present on the 
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Figure 4. Rev-Riplp Two-Hybrid Interactions 
(A) Summary table of two-hybrid interactions between Rev or Rex 
bait constructs and Rip1 p or Rev prey constructs. The bait constructs 
express LexA fused to Rev wild type (wt) (amino acids 1-116), Rev 
M10 (amino acids 1-116, LE78,79DL), Rev MB3 (amino acids 1-116, 
R41-43G), Rev effector wild type (amino acids 65-95), Rev effector 
M21 (amino acids 65-95, LT81,82DL), Rev effector M22 (amino acids 
65-95, LD83,84DL), and Rex wild type (amino acids 1-189). Each bait 
construct was tested for interaction with three prey plasmids: RIPlpl 
(the clone isolated in the screen and encoding amino acids 148-275 
of Rip1 p); RIP1 (encoding total Rip1 p), and Rev wild type. The different 
bait/prey interactions were analyzed in diploids using a mating assay 
(see Experimental Procedures). The number of pluses corresponds 
to blue color intensity on an X-Gal indicator plate as a result of lacZ 
gene activation (shown in [B]). 
(B) Analysis of the diploid strains described above on Ura His- Trp 
plus galactose and sucrose plus X-Gal indicator plates. 
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Figure 5. Amino Acid Sequence of Riplp 
The higly conserved FG residues of the degenerate XXFG tetrapeptide 
motif are shown in bold. The frequent serine, threonine, and aspara- 
gine residues are underlined, The boxed region (Rip lp l )  corresponds 
to the portion of the protein encoded by the clone isolated in the two- 
hybrid screen. 
prey expression vector (Figure 5). This suggests that the 
repeat domain is important for the interaction of Riplp 
with Rev. 
Riplp Localizes to Nuclear Pores 
To determine Riplp localization, we raised an anti-Riplp 
rabbit polyclonal antibody, which recognizes Riplp on 
Western blots of yeast extracts (data not shown). In a wild- 
type strain, we observed punctate perinuclear staining typ- 
ical of nuclear pores as well as some nucleoplasmic stain- 
ing (Figure 6A, left); in the RIP1 knockout (ARIP1) strain 
(see below), only the diffuse nucleoplasmic staining re- 
mained (Figure 6B, left). The results indicate that some 
nucleoplasmic staining is due to cross-reacting nuclear 
antigens. As a control for the integrity of the nuclear pores 
in the ARIP1 strain, the protein was stained with the mono- 
clonal antibody (MAb 414). This antibody recognizes sev- 
eral yeast nuclear pore proteins (Aris and Blobel, 1989) 
and gives indistinguishable punctate perinuclear staining 
in both the wild-type and ARIP1 strains (Figures 6A and 
6B, right). We also examined the nup133- strain (Figure 
6C, left). Deletion of the NUP133 gene does not affect 
growth at 25°C, but nup133- cells display clustering of 
nuclear pore corn plexes at one or a few sites on the nuclear 
envelope (Doye et al., 1994). When stained with MAb 414, 
the n up 133- cells show a crescent-shaped signal or a small 
number of intense spots at the nuclear periphery (Figure 
6C, right). With the anti-Rip1 p antibody, a qualitatively sim- 
ilar signal was observed (Figure 6C, left), but it was weaker 
and somewhat obscured by nucleoplasmic staining. We 
conclude that Riplp is indeed a nuclear pore-associated 
protein, but we cannot exclude the possibility that some 
Rip1 protein is also nucleoplasmic. 
Riplp Overexpression and RIP1 Gene Disruption 
Reduce the Rev Response 
If Riplp is important o Rev function in vivo, overexpres- 
sion of Riplp might influence the effects of Rev on gene 
expression. To test this prediction, we transformed yeast 
strains expressing wild-type Rev and the PC-CUP-RRE 
(or MC-CUP-RRE) reporter construct with a high copy 
number plasmid expressing total Riplp or the fragment 
Riplp2 (amino acids 120-229) from the strong constitutive 
gtyceraldehyde-3-phosphate d hydrogenase (GPD) pro- 
moter. The strains were also transformed with a high copy 
number plasmid expressing Rip1 p under the control of its 
own promoter, and growth of these triple transformants 
was compared at increasing copper concentrations (Fig- 
ure 7A). Overexpression of Riplp2 or Rip1 p decreased the 
copper resistance of the PC-CUP-RRE reporter strain, 
indicating that excess Rip1 p2 or Rip1 p reduced the posi- 
tive effect of Rev on pre-mRNA export. Similarly, overex- 
pression of Riplp2 or Riplp reduced the negative effect 
of Rev on mRNA expression, as it increased the copper 
resistance of the MC-CUP-RRE/Rev-containing strain. 
Significant overexpression was apparently required for the 
effects, as expression of Riplp from its own promoter had 
no effect and was comparable to addition of the vector 
control plasmid in both reporter systems (Figure 7A). The 
observed changes in copper resistance were also strictly 
dependent on the presence of Rev, since expression of 
the same constructs in a strain containing a control vector 
instead of the Rev-expressing plasmid had no effect on 
the copper growth phenotypes (data not shown). There 
were no growth effects of these plasmids, either alone 
or in combination, in the absence of copper. The results 
indicate that an interaction between Rev and R ip lp  can 
interfere with Rev function (see Discussion). 
The RIP1 gene was deleted by replacing the entire cod- 
ing region with the URA3 gene, which was subsequently 
eliminated by growth on 5-fluoroorotic acid (see Experi- 
mental Procedures; Atani et al., 1987). The ARIP1 strain 
grew indistinguishably from the parent strain at three dif- 
ferent temperatures, indicating that this gene is inessential 
and that its absence is without effect under these standard 
growth conditions. To assay the activity of Rev in the ab- 
sence of RIP1, we transformed the ARIP1 strain with yeast 
expression plasmids producing either wild-type Rev, M10 
mutant Rev, or no protein at all (vector control), as well 
as with the PC-CUP-RRE or the MC-CUP-RRE reporter 
constructs. Growth of the double transformants was exam- 
ined at increasing copper concentrations and compared 
with growth of the isogenic control strain (Figure 78). The 
absence of the RIP1 gene reduced the copper resistance 
of the PC-CUP-RRE/Rev strain (best seen at 1.1 mM 
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Figure 6. PunctateNuclearRimStainingofYeastCellsbyaPolyclonal Anti-RiplpAntibodyasDetectedbylndirectlmmunofluorescenceMicroscopy 
Wild-type (WT) (A), ARIP1 (B), and nup133- (C) (Doye et al., 1994) yeast cells were stained with a rabbit polyclonal anti-Riplp antibody (p ~Ripl) 
(left) or with MAb 414 (right). To identify the position of the nucleus, the same cells stained with DAPI are shown next o each picture. We were 
not able to generate a nup133lARIP1 double mutant strain, probably because these mutants are synthetic lethals. 
copper), indicating a decrease in the positive effect of Rev 
on pre-mRNA expression. Similarly, the absence of the 
RIP1 gene increased the copper resistance of the MC- 
CUP-RRE/Rev strain (best seen at 0.4 mM copper), indi- 
cating a decrease in the negative effect of Rev on mRNA 
expression. These changes in copper resistance were di- 
rectly related to Rev function, since the copper growth 
phenotypes of the reporter strains expressing M10 Rev 
or no Rev (vector control) were unaffected by the absence 
of RIP1 (Figure 7B). The data show that he RIP1 gene 
contributes to Rev function. 
Rev Interacts with Several Yeast Nucleoporins 
in the Two-Hybrid System 
Although the ARIP1 strain manifested substantially less 
Rev activity than the control wild-type strain, Rev still in- 
creased pre-mRNA expression and decreased mRNA ex- 
pression in this strain. We speculated that the residual 
activity of Rev might be due to interactions with other FG 
repeat-containing proteins. This notion is also based on 
experiments demonstrating redundant functions shared 
by other yeast nucleoporin genes (see Discussion). Be- 
cause a number of these genes are essential, it is difficult 
to assay directly their effects on Rev activity. Therefore, 
the repeat regions of five yeast nucleoporins, Nup159p 
(Gorsch et al., 1995), Nsplp (Nehrbass et al., 1990), 
Nuplp (Davis and Fink, 1990; Bogerd et al., 1994), 
Nupl00p (Wente et al., 1992), and Nup116p (Wimmer et 
al., 1992; Wente and Blobel, 1993), were tested for Rev 
interaction in the yeast two-hybrid assay. Based on the 
consensus sequence of their repeats, Nsplp and Nuplp 
are two members of the XFXFG nucleoporin family, 
whereas Nupl00p and Nup116p are two members of the 
GLFG family. The consensusXXFG present in the recently 
identified Nup159p (Gorsch et al., 1995) most closely re- 
sembles the Riplp repeat. A portion encoding between 
200 and 300 amino acids of the repeat region (comparable 
to the Riplpl  fragment) from each of these five nucleopor- 
ins was cloned into the two-hybrid prey vector, trans- 
formed into yeast, and mated with strains of opposite mat- 
ing type expressing the wild-type Rev bait or six other bait 
constructs (Figure 8; see also Figure 4). 
The data show that Rev interacts with the repeat regions 
from at least two other nucleoporins, Nup159p and 
Nupl00p (Figure 8). Although these interactions are 
weaker than those between Rev and Rip1 pl ,  the Nup159p 
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Figure 7. Riplp Overexpression and RIP1 Knockout 
(A) Rip1 p overexpression interferes with the activity of Rev. High copy 
number plasmids (LEU212#m) expressing Rip1 p sequences were intro- 
duced into yeast strains expressing wild-type Rev (TRP1/ARS1-CEN4) 
and either the PC-CUP-RRE or the MC-CUP-RRE reporter construct 
(URA312p.m). The overexpressing plasmids contained a portion of RIP1 
encoding amino acids 120-229 (GPD-Ripl p2) or total RIP1 encoding 
amino acids 1-430 (GPD-Riplp) under the control f the strong GPD 
promoter (Guthrie and Fink, 1991) or total Riplp driven by its own 
promoter (RIP1); a plasmid without insert was used as control (vector). 
The growth of the triple transformants was examined on plates con- 
taining increasing copper concentrations. 
(B) RIP1 knockout reduces the Rev response. The wild-type (WT) and 
the RIP1 knockout (ARIP1) strains were transformed with the PC- 
CUP-RRE or the MC-CUP-RRE reporter constructs (LEU212p.m) as 
well as with the wild-type Rev- or the M10 Rev-expressing piasmid 
or vector alone (TRP1/ARS1-CEN4). The growth of each double trans- 
formant was examined on selective plates containing increasing cop- 
per concentrations. 
and Nupl00p repeat regions interact with each bait in a 
way qualitatively comparable to R ip lp l ;  they also show 
specific interactions with the effector domains of Rev and 
Rex. This is consistent with the notion that Rev might un- 
dergo functionally significant interactions with a number 
of repeat-containing nucleoporins, thereby explaining the 
residual Rev activity in the ARIP1 strain. 
Discussion 
Consistent with recent experiments indicating that Rev 
has a direct effect on transport (Fischer et al., 1994), we 
report here a functionally relevant interaction between the 
effector domain of Rev and Riplp,  a novel candidate 
nucleoporin. The RIP1 gene was identified in a two-hybrid 
screen for yeast proteins that interact appropriately with 
the effector domain of Rev. The search was predicated 
on the conclusion that the general mode of action of Rev 
and the specific role of its effector domain are similar in 
yeast and in mammalian systems (Figures 2 and 3; Malim 
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Figure 8. Rev-Nucieoporin Two+Hybrid Interactions 
(A) Rev interacts with nucleoporin repeat domains. Summary table of, 
two-hybrid interactions between Rev or Rex and nucleoporin repeat 
domains. The interactions were examined  diploid strains using a 
mating assay as already described (see Figure 4; s e Experimental 
Procedures). The bait constructs are the same as those described 
in Figure 4A. The portion of the nucleoporin encoded by each prey 
construct is indicated at the top. The number of XXFG repeats encoded 
by the Riplpl and Nup159p fusions is 8 and 17, respectively. The 
number of XFXFG repeats encoded by the Nsplp and Nuplp fusions 
is 14 and 11, respectively. The number of GLFG repeats encoded by 
the N upl00p and N up116p fusions is 15 and 10, respectively, wt, wild 
type. 
(B) Analysis of the diploid strains described above on Ura- His Trp 
plus gatactose and sucrose plus X-Gal indicator plates. 
et al., 1989a; Stutz and Rosbash, 1994). As previously 
discussed (Stutz and Rosbash, 1994), the effect of Rev 
in yeast is modest as compared with mammalian systems. 
This might reflect the relatively high background of the 
yeast assay system (substantial cytoplasmic transport of 
pre-mRNA even in the absence of Rev) or weak conserva- 
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tion of the relevant components between yeast and mam- 
mals. Nonetheless, the effects of Riplp overexpression 
or of the RIP1 deletion on Rev function are substantial 
(Figure 7). Based on comparisons of copper resistance 
and CUP1 mRNA (or pre-mRNA) levels (Stutz and Ros- 
bash, 1994), we estimate that - 50% of the activity of Rev 
has been eliminated by Riplp overexpression or by the 
FLIP1 gene deletion. This implies that Riplp is a major 
component of the cellular machinery with which Rev inter- 
acts to promote RNA export. 
Searching for RIPs with a yeast genomic library has a 
number of advantages over using a human cDNA library. 
The size of the yeast genome means that a relatively small 
number of transformants i  sufficient o screen the ntire 
protein coding capacity of the organism. Moreover, every 
coding region is present at the same frequency, indepen- 
dent of its abundance in the mRNA population; in contrast, 
mammalian cDNA libraries require huge numbers of 
clones to include rare cDNAs with a reasonable probabil- 
ity. The issue of clone frequency is heightened by some 
additional experiments designed to characterize the na- 
ture of the interaction between Rev and Riplp. Preliminary 
results indicate that a minimum number of repeats is re- 
quired for a detectable association between Rev and 
Rip1 p, suggesting that some Riplp-containing clones may 
have scored negative in the two-hybrid assay. This under- 
scores the desirability of screening a complex library ex- 
pressing many versions of each gene as well as many dif- 
ferent genes. Finally, identification of an interacting yeast 
protein means that one can exploit the facile genetics of 
yeast to test whether the interaction is of significance to 
the function of Rev in vivo. 
Riplp has the canonical feature of nucleoporins (a class 
of yeast nuclear pore components), namely, the presence 
of a repeat domain rich in a few characteristic amino acids 
and devoid of acidic residues (Dingwall, 1993; Rout and 
Wente, 1994). Also, immunostaining experiments compar- 
ing wild-type and z~RIP1 strains indicate that some Riplp 
localizes to the nuclear pores (Figure 6). Based on the 
short repeated sequences, these nucleoporins have been 
subdivided into two families. Nupl p (Bogerd et al., 1994), 
Nup2p (Loeb et al., 1993), and Nsplp (Nehrbass et al., 
1990) belong to the XFXFG family, whereas Nup49p (Wim- 
mer et al., 1992), Nupl00p (Wente et al., 1992), Nup145p 
(Fabre et al., 1994; Wente and Blobel, 1994), and Nup116p 
(Wimmer et al., 1992; Wente and BIobel, 1993) form the 
GLFG family. Riplp appears to fall into a third category, 
since most of its repeats are ither SAFG, SPFG, or PSFG, 
with a consensus repeat of XXFG. The closest mammalian 
relative of Riplp identified in the database is the mamma- 
lian nucleoporin CAN1 (von Lindern et al., 1992; Kraemer 
et al., 1994); the CAN1 carboxy-terminal repeat region is 
30% identical to the Riplp repeat region. In the same 
search, the closest yeast relative corresponded to Rat7p/ 
Nup159p, which was identified in a screen for mutants 
impaired in RNA export and which localizes to the nuclear 
pore complex (Gorsch et al., 1995). Rat7p/Nup159p also 
contains repeats of the XXFG type in its central region, 
which shows 30% identity to the Riplp repeat region. 
Noteworthy is the fact that Riplp is relatively small com- 
pared with most known nucleoporins; in addition to its 
amino-terminal repeat domain, Rip1 p only contains a short 
(66 amino acids) unique carboxy-terminal sequence. 
An association with the nuclear pore complex would ex- 
plain the Riplp overexpression results (Figure 7A). Al- 
though expression of the Riplpl fragment presumably 
interferes with endogenous Riplp function and thereby 
inhibits Rev activity, one might have anticipated that over- 
expression of the complete protein would enhance Rev 
function (or perhaps have no effect). The observed inhibi- 
tory effect is explained by proposing that some stoichio- 
metric quantity of Riplp is normally assembled into the 
pore complex. The overexpressed protein would therefore 
be mislocalized and would compete with endogenous nu- 
clear pore-limited Riplp for binding to the effector domain 
of Rev. 
It is interesting and perhaps significant hat a tempera- 
ture-sensitive mutant in Rat7p/Nup159p has an even more 
rapid and selective effect on nuclear export of poly(A) RNA 
than conditional mutants of other nucleoporins that have 
also been proposed to play a role in RNA export (Fabre 
et al., 1994). As previously discussed (Elliott et al., 1994; 
Izaurralde and Mattaj, 1995; Gorsch et al., 1995), these 
observations make Rat7p/Nup159p the best candidate 
nucleoporin for having a specific role in promoting RNA 
export. Taken together with the effects of Riplp on Rev 
activity, these observations uggest that these two pro- 
teins may be members of a third family of nucleoporins 
specialized for the transport of RNA from the nucleus to 
the cytoplasm. Whether these yeast proteins function to 
transport selective RNA substrates remains to be deter- 
mined. 
Rev also interacts with the repeat regions of Rat7p/ 
Nup159p and Nupl00p. These interactions raise the gen- 
eral issues of howto interpret differences in the interaction 
of Rev with different nucleoporins in the two-hybrid assay, 
namely, the quantitative differences among the three posi- 
tive proteins and, most importantly, the qualitative differ- 
ences between these three proteins and the negative 
nucleoporins (Figure 8). We have not employed different 
two-hybrid systems, and it is possible that the negative 
proteins will be positive with a more sensitive assay. In 
addition, differences between different proteins (e.g., the 
difference between the positive Riplpl and the negative 
Nup116p) may not reflect comparable differences in inter- 
action strength, as low protein levels were observed by 
Western blotting in several cases (data not shown). Finally, 
we have some indication that the number of nucleoporin 
repeats present in the expressed fusion protein is im- 
portant for the interaction with the effector domain of Rev 
(data not shown). As a smaller number of repeats was 
present in the negative Nup116p, Nsplp, and Nuplp fu- 
sion proteins than in the positive Nup159p and Nupl00p 
proteins (Figure 8), an interaction with the negative pro- 
teins might have been detected had we assayed a larger 
number of nucleoporin repeats. These considerations not- 
Rev Effector Domain-Nucleoporin i teractions 
503 
NUCLEUS I CYTOPLASM 
PORE 
PROTEIN IMPORT ~ karyophertns 
(importin,SRP1 ,p97) 
RNP EXPORT I 
REV MEDIATED RNA EXPORT 
FG (RIP1) 
MI0 
Figure 9. Model for Mode of Action of Rev 
Protein import is currently modeled as occuring in two steps: docking 
of the nuclear localization signal (NLS)-containing substrate to the 
nuclear membrane followed by translocation of the substrate through 
the nuclear pore (Radu et al., 1995b). A cytoplasmic complex made 
of karyopherins ~ and 13 (importin, SRP1, and p97; Gorlich et al., 1994; 
Radu et al., 1995b; Weis et al., 1995) mediates the docking of nuclear 
localization signal-containing protein substrates to the nuclear pore 
by interacting with nucieoporin repeat motifs present on the cyto- 
plasmic side of the nuclear membrane. We speculate that nuclear 
export of RNPs, RNA, or protein functions similarly with a comparable 
nuclear activity (exportin) mediating the docking of substrates to the 
nuclear pore through an interaction with FG repeats present on the 
nucleoplasmic side; the role of Rev might be to mimic such an activity 
by mediating the docking of RRE-containing transcripts to the pore 
by interaction with FG-containing nucieoporins, thereby initiating the 
transtocation process. 
withstanding, R ip lp  is the strongest RIP we have de- 
tected, and the genetic data indicate that the interaction 
is biologically significant. 
Whether additional nucleoporins like Nup159p and 
Nup l00p  also contribute to the biological activity of Rev 
in yeast remains to be determined. However, a functional 
interaction between Rev and these other proteins is rea- 
sonable, if not expected. There are genetic experiments 
indicating that nuclear pore components are functionally 
redundant (Fabre et al., 1994; Wente and Blobel, 1994). 
The RIP1 gene is inessential and therefore probably contri- 
butes to nuclear pore function in a manner that overlaps 
that of other proteins. Most importantly, Rev still showed 
substantial biological activity in the ARIP1 strain (Figure 
7B), indicating that the effector domain interacts with other 
cellular components. We therefore expect that more than 
one FG-containing protein will be relevant to the biological 
activity of Rev. 
Although there are now strong indications that the pri- 
mary function of Rev is to promote nuclear transport 
(Malim and Cullen, 1993; Fischer et al., 1994; Brighty and 
Rosenberg, 1994; Nasioulas et al., 1994), an independent 
or related role in splicing inhibition is not excluded (Lu et 
al., 1990; Chang and Sharp, 1989; Kjems et al., 1991b; 
Luo et al., 1994). In the yeast system, there are two splicing 
mutants that are epistatic to the effect of Rev on RNA 
transport (Stutz and Rosbash, 1994). This suggests that 
transport across the nuclear membrane cannot override 
certain associations between pre-mRNA and splicing 
components, and this view is consistent with the fact that 
the natural targets of Rev are inefficient splicing sub- 
strates. An association between Rev and pore compo- 
nents suggests that spl iceosome disassembly might be 
accelerated at the nuclear pore. This would provide Rev 
with a role in splicing inhibition, but only indirectly through 
its association with nuclear pore components. 
The interaction between yeast nucleoporins and the ef- 
fector domain of Rev might enhance some specific bio- 
chemical step associated with transport, or it might more 
generally serve to raise the local concentration or deliver 
target transcripts to the nuclear envelope. The latter view 
suggests that Rev might play a nuclear role in promoting 
the export of RRE-containing RNAs similar to the cyto- 
plasmic role played by the (~ and 13 karyopherins (importin, 
SRP1, and p97; Moore and Blobel, 1992; Gorlich et al., 
1994; Moroianu et al., 1995; Radu et al., 1995a, 1995b; 
Weis et al., 1995) in promoting the nuclear import of nu- 
clear localization s ignal-containing proteins (Figure 9). As 
we cannot exclude the fact that some Rip1 p is nucleoplas- 
mic, it is possible that Rip1 p functions in concert with Rev 
to mediate the docking of RRE-containing transcripts to 
the nuclear pore. Further progress in understanding the 
mode of action of Rev should continue to il luminate the 
rather poorly understood process of RNA transport. 
Experimental Procedures 
Plasmid Constructions 
The PC-CUP-RRE (LEU2121~m) and MC-CUP-RRE (LEU2/21~m) re- 
porter constructs have been described previously (Stutz and Rosbash, 
1994). URA312~m versions of the same reporter constructs were used 
in the Riplp overexpression experiment. 
The Rev-expressing plasmids were obtained by PCR amplification 
of wild-type or mutant Rev sequences (Malim et al., 1989a) with two 
oligo primers containing Bcll sites. The PCR fragments were cloned 
into the BamHI site behind the GPD promoter of the yeast TRPll2~m 
expression vector pG1 (Guthrie and Fink, 1991) or a centromeric ver- 
sion thereof, as described earlier (Stutz and Rosbash, 1994), to create 
pG1Rev and pG1Rev/ARS1-CEN4, respectively. The Rev-Rex chi- 
meric constructs were a gift from T. Hope and were subcloned into 
the BamHI site of pG1TRPI/ARS1 -CEN4 after PCR amplification with 
primers introducing Bcll sites. 
The wild-type Rev construct (URA3/ARS1-CEN4) used in the domi- 
nant negative experiment was obtained by transferring the wild-type 
Rev expression cassette from pG1 Rev into YCP50; the wild-type Rev 
cassette was purified from pG1 Rev by digestion with Xbal and Hindtll 
and cloned into the Hindlll site of YCP5O using Hindlll linkers. 
To overexpress Riplp from the strong constitutive GPD promoter, 
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a 330 bp fragment encoding amino acids 121-229 (Rip1 p2) or a 1290 
bp fragment encoding the whole 430 amino acid protein (Rip1 p) were 
PCR amplified. The 5' and 3' primers contained a BamHI and a Xhol 
site, respectively, and the PCR products were cloned into the expres- 
sion vector FS3 (LEU212p.m) cut with BamHI and Sail. FS3 was obtained 
by transferring, from the pG1 vector (Guthrie and Fink, 1991), a Hindlll- 
Xbal fragment containing the GPD promoter, the polycloning site, and 
the PGK terminator into the BamHI site of vector JH21 (LEU212p.m) 
by using Bglll linkers. The RIP1 genomic clone present on a LEU21 
2~m plasmid was used to 0verexpress the whole protein from its own 
promoter. 
Two-Hybrid Vectors and Strains 
The following bait constructs were all made as LexA fusions into the 
EcoRI and Sail sites of pLexA (amino acids 1-202) plus PL (H/S31 
2~m) (Ruden et al., 1991; Gyuris et al., 1993): Rev wild type (amino 
acids 1-116, total protein), Rev MB3 (amino acids 1-116, R41-43G), 
Rev M10 (amino acids 1-116, LE78,79DL), effector wild type (Rev 
amino acids 65-95), effector M21 (Rev amino acids 65-95, LT81, 
82DL), effector M22 (Rev amino acids 65-95, LD83,84DL), and Rex 
wild type (amino acids 1-189, total protein). The prey constructs used 
for the analysis of specific interactions were made by PCR amplifica- 
tion from cloned or genomic DNA and EcoRl-Xhol insertion into 
pJG4-5 (TRPll2v, m) (Gyuris et al., 1993) and are as follows: Riplpl 
(amino acids 148-271), Riplp (amino acids 1-430),-Rev wild tyl~e 
(amino acids 1-116), Nup159p (amino acids 497-701), Nsplp (amino 
acids 296-608), N up1 p (amino acids 438-737), Nup 100p (amino acids 
278-534), and Nup116p (amino acids 458-701). 
The strain EGY48 (MATa, trpl, ure3, LEU2::p/exop6-LEU2) contains 
both the integrated LEU2 reporter LexA-op-LEU2 (Gyuris et al., 1993) 
and the/ecZ reporter pSH18-34 on a URA3121~m plasmid, a gift of R. 
Finley and R. Brent. RFY206 (MATa, his3, /eu2, ura3, trpl, /ys2), a 
gift from R. Finley, also contains the/acZ reporter pSH18-34. 
Yeast Two-Hybrid Screen 
The yeast two-hybrid system used in the screen was provided and 
used as described by Gyuris et al. (1993) with the following modifica- 
tions. The prey, a yeast genomic library made by cloning Alul and 
Haelll partially digested DNA into the EcoRI site downstream of the 
activation domain in pJG4-5, was transformed (Ito et al., 1983) into 
strain EGY48 containing the Rev MB3 bait construct. Transformants 
(4.6 x 104) were selected on U ra- Hie- Trp plus glucose (2%) medium. 
The colonies were scraped in TE buffer and resuspended in one pellet 
volume of 65% glycerol, 0.1 M MgSO4, 25 mM Tris (pH 8,0) and stored 
in 200 p.I aliquots at -80°C. The titer of the library was determined 
on Ura His- Trp plus galactose (3%) and sucrose (1%) medium; 
following a 4 hr galactose induction in liquid, 5 x 107 colonies were 
grown on five standard 150 mmx 15 mm Ura- His Trp Leu plus 
galactose (3%) and sucrose (1%) plates: -1000 Leu + colonies ap- 
peared; 162 of these colonies were tested, 156 of which were positive 
for galactose-dependent blue color (lacZ induction) on Ura- His Trp 
plus gatactose (3%) and sucrose (1%) plus X-Gal indicator plates. 
pJG4-5 plasmids were rescued and analyzed for insert size by both 
PCR (using primers designed on either side of the EcoRI cloning junc- 
tion) and EcoRI restriction analysis. The candidate prey plasmids con- 
taining inserts were further characterized in a mating assay (described 
below). 
Two-Hybrid Subscreen and Mating Assay 
A mating assay was used as a secondary screen to eliminate candi- 
dates not specifically interacting with the effector domain of Rev. Prey 
candidates were transformed into EGY48, selected on Ura- Trp me- 
dium, and mated to strain RFY206 containing the following panel of 
bait constructs described above (all were LexA fusions): Rev wild type, 
Rev M10, Rev MB3, effector wild type, effector M21, effector M22, 
Rex wild type, and LexA DNA-binding domain alone. Diploids were 
selected by growth on Ura- His Trp medium and tested for galactose- 
dependent activation of the reporter genes. The criteria for a RIP (posi- 
tive interaction with Rev wild type and effector wild type, while negative 
with Rev M10 or effector M21 or M22) were met by one candidate, 
Riplp. 
Genomic Clone and Sequencing Analysis 
Two primers in the pJG4-5 vector near the 5' and 3' ends of the EcoRI 
insert were designed and used for the first round of sequencing. The 
complete R/P1 gene was isolated from a YEp13 yeast genomic library 
(Lagosky et al,, 1987) by colony hybridization, probed with the random- 
primed labeled R/P1 EcoRI fragment purified from the two-hybrid clone 
(Maniatis et al., 1982). Automated sequencing of the genomic clone 
was facilitated by using primers designed internally to the known R/P1 
sequence. The program BLAST was used when comparing the DNA 
and predicted protein sequences to the GenBank and EMBL data- 
bases. 
Yeast Strains and Copper Growth Assay 
The copper growth assay and the wild-type copper-sensitive strain 
Y59ACUP1 (MA Ta, /eu2.112, ura3-52, trp-289, arg4, ado2, ACUP1) 
have been described previously (Stutz and Rosbash, 1994). 
The RIP1 knockout strain (Y59ACUPARIP1) was generated from 
the haploid Y59ACUP1 strain. The complete R/P1 coding region (from 
the Aval site 20 nt upstream of the ATG to the Stul site 40 nt before 
the TAG stop codon) was deleted by homologous recombination using 
a construct that contained the HisG-URA3-HisG 3.8 kb fragment 
(Alani et al., 1987) flanked by 0.7 and 0.5 kb of RIP1 5' and 3' flanking 
sequences. The whole insert was released from pBluescript II KS by 
Xhol and Notl double digestion before transformation. R/P1 gone dis- 
ruption was verified by Southern blot analysis, and uracil auxotrophy 
of the •RIP1 strain was recovered by growth on 5-fluoroorotic acid 
(Alani et al., 1987). 
Immunofluorescence 
The above-described wild-type and ARIP1 or the temperature-sensitive 
nup133- (Doye et al., 1994) yeast cells were grown to early log phase 
at 30°C or 25°C, respectively, fixed, and processed for immunofluores- 
cence essentially as described previously (Wente et al., 1992); the 
fixation was done for 8 rain; pictures were taken with a Zeiss Axiophot 
microscope. The rabbit polyclonal anti-Riplp antibody was raised by 
injection of a GST-Riplp fusion protein encoding amino acids 120- 
229 of Riplp and was used at a 1:500 dilution (AGMED). The secondary 
antibody was a goat anti-rabbit IgG-FITC conjugate (dilution of 1:80; 
Sigma ImmunoChemicals). To stain for nucleoporins, we used MAb 
414 (Aris and Blobel, 1989; BABCO) at a dilution of 1:100 followed 
by FITC-conjugated goat anti-mouse IgG (dilution of 1:100; Jackson 
Immunoresearch Laboratories). 
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